ArticleNature medicine2016

A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.

Elizabeth A Traxler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.